Monsanto (NYSE:MON) price target upped to $102.20, released a report earlier today by Monness
- Updated: October 2, 2016
Yesterday Monsanto (NYSE:MON) traded 0.40% higher at $0.00. MON’s 50-day moving average is $105.13 and its 200-day moving average is $101.01. With the last close down 1.17% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 3,664,554 shares of MON traded hands, down from an average volume of 4,060,710
In a report issued Monday October 03, 2016 Monness bumped up the target of Monsanto (NYSE:MON) to $102.20 reporting a potential upside of 0%.
See Chart Below
With a market capitalization of $0, Monsanto has 52 week low of $83.73 and a 52 week high of $114.26 with a P/E ratio of 44.98 .
Also covering Monsanto's stock price target, a total of 19 brokers have issued a research note on the company. The average stock price target is $98.37 with 3 firms rating the company a strong buy, ten analysts rating the company a buy, eight brokerages rating the company a hold, two analysts rating the company a underperform, and lastly one broker rating the stock a sell.
Brief Synopsis About Monsanto (NYSE:MON)
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its Seeds and Genomics segment, the Company produces seed brands, including DEKALB, Asgrow, Deltapine, Seminis and De Ruiter, and it develops biotechnology traits that assist farmers in controlling insects and weeds and precision agriculture to assist farmers in decision-making. It offers products, such as Germplasm and Biotechnology traits. Through its Agricultural Productivity segment, the Company manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.